Press Releases

MGEN $2.25 $ - 0.08 (3.43%)

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
5/28/2019
4:30 PM ET
Press Release

miRagen Therapeutics to Present a Corporate Overview at the Jefferies 2019 Global Healthcare Conference

5/28/2019

BOULDER, Colo., May 28, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific f...

 Continue Reading
5/21/2019
7:00 AM ET
Press Release

miRagen Presents Preclinical Data in Pulmonary Fibrosis Using Second Generation microRNA-29 Replacement Product Candidate at the 2019 American Thoracic Society International Conference

5/21/2019

BOULDER, Colo., May 21, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therap...

 Continue Reading
5/8/2019
4:01 PM ET
Earnings Release

miRagen Announces First Quarter 2019 Financial Results and Provides Corporate Update

5/8/2019

Initiated patient dosing in the SOLAR Phase 2 trial for cobomarsen Released updated clinical data from the Phase 1 trial of cobomarsen in ATLL patientsReleased data from preclinical studies showing th...

 Continue Reading
4/29/2019
7:00 AM ET
Press Release

miRagen Therapeutics Announces New Data Supporting the Potential Use of Remlarsen to Prevent Corneal Fibrosis at the 2019 ARVO Meeting

4/29/2019

Preclinical data indicate that remlarsen accelerated the healing of corneal injury when compared to placebomiRagen believes the study’s results support that remlarsen may offer a novel therapeutic for...

 Continue Reading
4/26/2019
7:00 AM ET
Press Release

miRagen Announces New Clinical Data for Cobomarsen in ATLL Patients at the 19th Annual HTLV Congress in Lima, Peru

4/26/2019

Continued evidence of disease stabilization observed in ATLL patients treated with cobomarsen for up to 16 monthsCobomarsen allowed for rapid bone marrow recovery following chemotherapyIn most patient...

 Continue Reading
Displaying 1 to 5 (of 78 releases)